Browsing Category
Pharma Industry News
4753 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Lyell Immunopharma to acquire ImmPACT—are CAR T-cell therapies the future of oncology?
Lyell Immunopharma is making waves with its strategic acquisition of ImmPACT Bio, a move aimed at bolstering its…
West Pharmaceutical Services shares surge 19% following upgraded 2024 outlook
West Pharmaceutical Services Inc. (NYSE: WST) witnessed a significant 19% jump in its share price after it revised…
Piramal Pharma posts robust Q2 growth, expands Lexington facility to meet demand
Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635) has reported strong growth for the second quarter (Q2) and…
Mankind Pharma expands dominance in women’s health with Bharat Serums and Vaccines acquisition
Mankind Pharma Limited has announced the completion of its acquisition of Bharat Serums and Vaccines Limited (BSV) for…
UK approves Lilly’s Alzheimer’s drug but labels it ‘too expensive’ for NHS use
The UK has approved Eli Lilly’s new Alzheimer’s treatment, donanemab, which has shown promise in slowing cognitive decline.…
Sanofi enters exclusive talks with CD&R over $17bn Opella deal
Sanofi has confirmed its exclusive negotiations with Clayton, Dubilier & Rice (CD&R) for the sale of a 50%…
Coya Therapeutics stock surges as investors pump $10m into growth
Coya Therapeutics Inc. (NASDAQ: COYA) witnessed a 9% increase in its share value after securing $10 million through…
FDA approval pathway propels Sangamo Therapeutics shares upward: what’s next?
Sangamo Therapeutics experienced a significant surge in its stock price, jumping by as much as 53%, after the…
Samsung Biologics bags $1.24bn CDMO contract with Asia-based pharma firm
Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), has signed its largest-ever contract, valued…
Foresee Pharmaceuticals reports positive Phase 1 trial results for Linvemastat
Foresee Pharmaceuticals (TPEx: 6576) has reported successful preliminary results from its Phase 1 clinical trial of linvemastat (FP-020),…